Keynard Edouard M.S.

Recommended Articles

• Alternative Treatments for Testicular Cancer?

  According to studies, 98 percent of people afflicted by cancers exposed to chemotherapy and radiation treatment succumb to their ailments which contrasts starkly with billions of dollars that have gone into researching cancer cures.Cancer affecting the germ cells lining the seminiferous tubules of...

• Treatment for Mumps

  Mumps is a highly contagious viral infection. It usually attacks the parotid glands but sometimes, it can affect other parts of the body. Mumps is common in young children, but can develop at any age. The causative virus for mumps is known as paramyxoviruses. It’s spread through contact with...

• Hearing Loss: All You Need to Know About Hearing Loss

  Hearing loss or hearing impairment is defined as a partial or complete inability to hear. People who have chronic ear infections mostly develop hearing loss. However, the condition can also be caused by several reasons such as aging, heredity, noise pollution, and certain diseases or...

• Sleep Apnea: What Are the Causes, Symptoms, and Treatment?

  Sleep apnea is a very common but serious sleeping disorder, wherein your breathing gets briefly interrupted while you sleep. Breathing might stop or become very shallow with pauses while you are sleeping. It can last from a few seconds to several minutes and usually recurs through the night. Since...

• Oscar Winner Kathy Bates Talks About Learning She Had Ovarian and Breast Cancer

  Breast and ovarian cancer are serious diseases that can affect any woman. Both can be terrifying to have, and no woman wants to hear those dreaded words from her doctor.Cancer is responsible for millions of deaths every year, and though modern medicine has come a long way to treat this disease,...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...